Hypertension and cardiac hypertrophy
When angiotensinogen levels increase, more angiotensinogen will be converted to ANG I by renin. ACE converts ANG I to ANG II, which then increase blood pressure, ANG II also increase aldosterone release in the adrenal cortex. ANG II also contribute to cardac hypertrophy which can lead to miocardial infarction which leads to heart failure.
ACE inhibitors, not only inhibit the conversion of ANG to ANG II, but also prevent bradykinin metabolism. Which leads to level of bradykinin increasing, and can acuse side effects like dry cough.
ACE inhibitors works in two ways, 1. Inhibiting the conversion of ANG I to ANG II, and 2. Blocking ANG II type 1 receptors. This causes vasoconstriction, decreasing peripheral resistance and lowering blood pressure. Aldosterone levels decrease, leading to less salt and water retention which decrease CO, cardiac preload and lower blood pressure. ACE inhibitors also prevent bradykinin metabolism which can lead to increased levels of bradykinin and increase arterial vasodilation, lower PR and lowers blood pressure.
Losartan and similar drugs are competitive antagonists at angiotensin AT₁ receptors, but has no effect of angiotensin 2 receptors.
Kinins produce arteriolar dilation which is an effect of kinins on arteriolar smooth muscle mediated by nitrite oxide of vasodilation prostaglandins. Kinins causes contraction in veins due to contraction in visceral smooth muscle.
Bradykinin 2 receptors.
Natriuretic peptides causes vasodilation that leads to decrease in PR and lowers blood pressure in patients with hypertension. These peptides also increase glomerular filtration which leads to more sodium excretion and decreasing sodium reabsorption, thus treating oedema that is associated with congestive heart failure.
Neprilysin metabolises natriuretic peptides, inhibiting Neprilysin leading vasodilation of ANP and BNP level increase and increase in renin secretion leading to higher levels of ANG II, helping in treatment of heart failure.
Drug name: Sacubitril
Vasodilators: Bosentan, macitentan, ambrisentan, sitaxsentan.
Vasoconstrictors: Endothelin 1,2,3